APO RESEARCH · REPORT
GABA
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Product & engineering
Understand the product.
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Selected research
Market Structure
Global GABA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Global GABA (CAS 56-12-2) key players include Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Sino Biotek, Zhejiang Yiwan Bio, etc. Global top five manufacturers hold a share about 45%. China is the largest market, with a share about 90%, followed by Japan, have a share over 3 percent. In terms of Production, Microbial Fermentation (feed grade) is the largest segment, with a share over 77%. And in terms of Application, the largest application is Food, followed by Medicine, Plant Growth Promoter, etc.
The report provides an overview of the global GABA market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of GABA and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GABA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA market size, projected growth trends, production technologies, key applications, and end-use industries.
GABA Segment by Company
Pharma Foods International
Kyowa Hakko
Sekisui Chemical
Sino Biotek
Zhejiang Yiwan Bio
Shanghai Richen
Luckerkong
Qandr Biology
Bloomage Biotech
Jyswkj
Zjtr Chemistry
Xinyou Chemistry
Bornsun Biology
Huarui Biology
Viab Life
Microbiofeed
Harworld
GABA Segment by Type
Microbial Fermentation (Feed Grade)
Microbial Fermentation (Food Grade)
Chemical Synthesis
GABA Segment by Application
Animal Feed
Food
Medicine
Plant Growth Promoter
Cosmetic
Other
GABA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GABA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the GABA market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GABA industry.
Chapter 3: Detailed analysis of GABA market competition landscape. Including GABA manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of GABA by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of GABA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microbial Fermentation (Feed Grade)
- Microbial Fermentation (Food Grade)
- Chemical Synthesis
Applications
- Animal Feed
- Food
- Medicine
- Plant Growth Promoter
- Cosmetic
- Other
Companies covered
- Pharma Foods International
- Kyowa Hakko
- Sekisui Chemical
- Sino Biotek
- Zhejiang Yiwan Bio
- Shanghai Richen
- Luckerkong
- Qandr Biology
- Bloomage Biotech
- Jyswkj
- Zjtr Chemistry
- Xinyou Chemistry
- Bornsun Biology
- Huarui Biology
- Viab Life
- Microbiofeed
- Harworld
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global GABA Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global GABA Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global GABA Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global GABA Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global GABA Market Dynamics
- 2.1 GABA Industry Trends
- 2.2 GABA Industry Drivers
- 2.3 GABA Industry Opportunities and Challenges
- 2.4 GABA Industry Restraints
3 GABA Market by Manufacturers
- 3.1 Global GABA Production Value by Manufacturers (2021-2026)
- 3.2 Global GABA Production by Manufacturers (2021-2026)
- 3.3 Global GABA Average Price by Manufacturers (2021-2026)
- 3.4 Global GABA Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GABA Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global GABA Manufacturers, Product Type & Application
- 3.7 Global GABA Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global GABA Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 GABA Players Market Share by Production Value in 2025
- 3.8.3 2025 GABA Tier 1, Tier 2, and Tier 3
4 GABA Market by Type
- 4.1 GABA Type Introduction
- 4.1.1 Microbial Fermentation (Feed Grade)
- 4.1.2 Microbial Fermentation (Food Grade)
- 4.1.3 Chemical Synthesis
- 4.2 Global GABA Production by Type
- 4.2.1 Global GABA Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global GABA Production by Type (2021-2032)
- 4.2.3 Global GABA Production Market Share by Type (2021-2032)
- 4.3 Global GABA Production Value by Type
- 4.3.1 Global GABA Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global GABA Production Value by Type (2021-2032)
- 4.3.3 Global GABA Production Value Market Share by Type (2021-2032)
5 GABA Market by Application
- 5.1 GABA Application Introduction
- 5.1.1 Animal Feed
- 5.1.2 Food
- 5.1.3 Medicine
- 5.1.4 Plant Growth Promoter
- 5.1.5 Cosmetic
- 5.1.6 Other
- 5.2 Global GABA Production by Application
- 5.2.1 Global GABA Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global GABA Production by Application (2021-2032)
- 5.2.3 Global GABA Production Market Share by Application (2021-2032)
- 5.3 Global GABA Production Value by Application
- 5.3.1 Global GABA Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global GABA Production Value by Application (2021-2032)
- 5.3.3 Global GABA Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Pharma Foods International
- 6.1.1 Pharma Foods International Company Information
- 6.1.2 Pharma Foods International Business Overview
- 6.1.3 Pharma Foods International GABA Production, Value and Gross Margin (2021-2026)
- 6.1.4 Pharma Foods International GABA Product Portfolio
- 6.1.5 Pharma Foods International Recent Developments
- 6.2 Kyowa Hakko
- 6.2.1 Kyowa Hakko Company Information
- 6.2.2 Kyowa Hakko Business Overview
- 6.2.3 Kyowa Hakko GABA Production, Value and Gross Margin (2021-2026)
- 6.2.4 Kyowa Hakko GABA Product Portfolio
- 6.2.5 Kyowa Hakko Recent Developments
- 6.3 Sekisui Chemical
- 6.3.1 Sekisui Chemical Company Information
- 6.3.2 Sekisui Chemical Business Overview
- 6.3.3 Sekisui Chemical GABA Production, Value and Gross Margin (2021-2026)
- 6.3.4 Sekisui Chemical GABA Product Portfolio
- 6.3.5 Sekisui Chemical Recent Developments
- 6.4 Sino Biotek
- 6.4.1 Sino Biotek Company Information
- 6.4.2 Sino Biotek Business Overview
- 6.4.3 Sino Biotek GABA Production, Value and Gross Margin (2021-2026)
- 6.4.4 Sino Biotek GABA Product Portfolio
- 6.4.5 Sino Biotek Recent Developments
- 6.5 Zhejiang Yiwan Bio
- 6.5.1 Zhejiang Yiwan Bio Company Information
- 6.5.2 Zhejiang Yiwan Bio Business Overview
- 6.5.3 Zhejiang Yiwan Bio GABA Production, Value and Gross Margin (2021-2026)
- 6.5.4 Zhejiang Yiwan Bio GABA Product Portfolio
- 6.5.5 Zhejiang Yiwan Bio Recent Developments
- 6.6 Shanghai Richen
- 6.6.1 Shanghai Richen Company Information
- 6.6.2 Shanghai Richen Business Overview
- 6.6.3 Shanghai Richen GABA Production, Value and Gross Margin (2021-2026)
- 6.6.4 Shanghai Richen GABA Product Portfolio
- 6.6.5 Shanghai Richen Recent Developments
- 6.7 Luckerkong
- 6.7.1 Luckerkong Company Information
- 6.7.2 Luckerkong Business Overview
- 6.7.3 Luckerkong GABA Production, Value and Gross Margin (2021-2026)
- 6.7.4 Luckerkong GABA Product Portfolio
- 6.7.5 Luckerkong Recent Developments
- 6.8 Qandr Biology
- 6.8.1 Qandr Biology Company Information
- 6.8.2 Qandr Biology Business Overview
- 6.8.3 Qandr Biology GABA Production, Value and Gross Margin (2021-2026)
- 6.8.4 Qandr Biology GABA Product Portfolio
- 6.8.5 Qandr Biology Recent Developments
- 6.9 Bloomage Biotech
- 6.9.1 Bloomage Biotech Company Information
- 6.9.2 Bloomage Biotech Business Overview
- 6.9.3 Bloomage Biotech GABA Production, Value and Gross Margin (2021-2026)
- 6.9.4 Bloomage Biotech GABA Product Portfolio
- 6.9.5 Bloomage Biotech Recent Developments
- 6.10 Jyswkj
- 6.10.1 Jyswkj Company Information
- 6.10.2 Jyswkj Business Overview
- 6.10.3 Jyswkj GABA Production, Value and Gross Margin (2021-2026)
- 6.10.4 Jyswkj GABA Product Portfolio
- 6.10.5 Jyswkj Recent Developments
- 6.11 Zjtr Chemistry
- 6.11.1 Zjtr Chemistry Company Information
- 6.11.2 Zjtr Chemistry Business Overview
- 6.11.3 Zjtr Chemistry GABA Production, Value and Gross Margin (2021-2026)
- 6.11.4 Zjtr Chemistry GABA Product Portfolio
- 6.11.5 Zjtr Chemistry Recent Developments
- 6.12 Xinyou Chemistry
- 6.12.1 Xinyou Chemistry Company Information
- 6.12.2 Xinyou Chemistry Business Overview
- 6.12.3 Xinyou Chemistry GABA Production, Value and Gross Margin (2021-2026)
- 6.12.4 Xinyou Chemistry GABA Product Portfolio
- 6.12.5 Xinyou Chemistry Recent Developments
- 6.13 Bornsun Biology
- 6.13.1 Bornsun Biology Company Information
- 6.13.2 Bornsun Biology Business Overview
- 6.13.3 Bornsun Biology GABA Production, Value and Gross Margin (2021-2026)
- 6.13.4 Bornsun Biology GABA Product Portfolio
- 6.13.5 Bornsun Biology Recent Developments
- 6.14 Huarui Biology
- 6.14.1 Huarui Biology Company Information
- 6.14.2 Huarui Biology Business Overview
- 6.14.3 Huarui Biology GABA Production, Value and Gross Margin (2021-2026)
- 6.14.4 Huarui Biology GABA Product Portfolio
- 6.14.5 Huarui Biology Recent Developments
- 6.15 Viab Life
- 6.15.1 Viab Life Company Information
- 6.15.2 Viab Life Business Overview
- 6.15.3 Viab Life GABA Production, Value and Gross Margin (2021-2026)
- 6.15.4 Viab Life GABA Product Portfolio
- 6.15.5 Viab Life Recent Developments
- 6.16 Microbiofeed
- 6.16.1 Microbiofeed Company Information
- 6.16.2 Microbiofeed Business Overview
- 6.16.3 Microbiofeed GABA Production, Value and Gross Margin (2021-2026)
- 6.16.4 Microbiofeed GABA Product Portfolio
- 6.16.5 Microbiofeed Recent Developments
- 6.17 Harworld
- 6.17.1 Harworld Company Information
- 6.17.2 Harworld Business Overview
- 6.17.3 Harworld GABA Production, Value and Gross Margin (2021-2026)
- 6.17.4 Harworld GABA Product Portfolio
- 6.17.5 Harworld Recent Developments
7 Global GABA Production by Region
- 7.1 Global GABA Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global GABA Production by Region (2021-2032)
- 7.2.1 Global GABA Production by Region (2021-2026)
- 7.2.2 Global GABA Production Forecast by Region (2027-2032)
- 7.3 Global GABA Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global GABA Production Value by Region (2021-2032)
- 7.4.1 Global GABA Production Value by Region (2021-2026)
- 7.4.2 Global GABA Production Value by Region (2027-2032)
- 7.5 Global GABA Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America GABA Production Value (2021-2032)
- 7.6.2 Europe GABA Production Value (2021-2032)
- 7.6.3 Asia-Pacific GABA Production Value (2021-2032)
- 7.6.4 South America GABA Production Value (2021-2032)
- 7.6.5 Middle East & Africa GABA Production Value (2021-2032)
8 Global GABA Consumption by Region
- 8.1 Global GABA Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global GABA Consumption by Region (2021-2032)
- 8.2.1 Global GABA Consumption by Region (2021-2026)
- 8.2.2 Global GABA Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America GABA Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe GABA Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific GABA Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America GABA Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa GABA Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 GABA Value Chain Analysis
- 9.1.1 GABA Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 GABA Production Mode & Process
- 9.2 GABA Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 GABA Distributors
- 9.2.3 GABA Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst